
	Joel Jung is an experienced financial executive who has spent nearly two decades guiding financial strategy in the high-tech and biotechnology industry. Before joining BioNano Genomics in 2014, Joel was CFO of Agraquest, Inc., a private, VC-backed company where he led the company&rsquo;s finance, accounting and information technology groups. During his tenure, he helped complete the successful sale of the company to Bayer CropScience.
	
	Prior to his role with Agraquest, Joel was CFO and Treasurer of Celera Corporation, a publicly-traded company, having led the financial activities for the spin-out from an operating division of the Applera Corporation.&nbsp; Prior to Celera, he held several executive financial positions with Chiron Corporation including Vice President Finance for the Blood Testing Division, and Vice President and Corporate Treasurer prior to the acquisition of the company by Novartis.&nbsp; Joel holds an MBA in Finance from the University of California, Berkley as well as a B.S. degree with distinction from Purdue University in Aeronautical and Astronautical Engineering.
